Literature DB >> 11592731

Evidence for specific ceramidase present in the intestinal contents of rats and humans.

R D Duan1, Y Cheng, L Yang, L Ohlsson, A Nilsson.   

Abstract

A neutral ceramidase activity stimulated by bile salt was previously identified in the intestinal content. Recently, bile salt stimulated lipase (BSSL) was found to have ceramidase activity. It is unknown whether the ceramidase activity previously found is attributable to BSSL. To address this question, we compared the behaviors of high quaternary aminoethyl (HQ) anion exchange chromatography, the distributions, the stability, and the responses to lipase inhibitor between ceramidase and pancreatic BSSL. The proteins from whole small intestinal contents of humans and rats were precipitated by acetone and dissolved in 20 mM Tris buffer pH 8.2. These proteins had neutral ceramidase activity but not BSSL activity against p-nitrophenyl acetate. When the proteins were subject to HQ chromatography, two peaks of ceramidase activity were identified, which had acid and neutral pH optima, respectively. Neither of them had BSSL activity against p-nitrophenyl acetate. Western blot using BSSL antiserum failed to identify BSSL protein in the fractions with high neutral ceramidase activity. In rat intestinal tract, pancreatic BSSL activity was high in the duodenum and declined rapidly in the small intestine, whereas neutral ceramidase activity was low in the duodenum and maintained a high level until the distal part of the small intestine. In addition, orlistat, the inhibitor of lipase, abolished human BSSL activity against p-nitrophenyl acetate and slightly reduced its activity against ceramide but had no inhibitory effect on ceramidase activity isolated by HQ chromatography. In conclusion, we provide the evidence for a specific ceramidase other than pancreatic BSSL present in the intestinal content. The enzyme may play important roles in digestion of dietary sphingolipids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592731     DOI: 10.1007/s11745-001-0788-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.

Authors:  M Tani; N Okino; S Mitsutake; T Tanigawa; H Izu; M Ito
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 2.  Sphingomyelin hydrolysis in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases.

Authors:  R D Duan
Journal:  Scand J Gastroenterol       Date:  1998-07       Impact factor: 2.423

3.  Metabolism of sphingomyelin in the intestinal tract of the rat.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1968-12-18

4.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1969-03-04

5.  Distribution and properties of neutral ceramidase activity in rat intestinal tract.

Authors:  P Lundgren; A Nilsson; R D Duan
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

6.  Digestion of ceramide by human milk bile salt-stimulated lipase.

Authors:  L Nyberg; A Farooqi; L Bläckberg; R D Duan; A Nilsson; O Hernell
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-11       Impact factor: 2.839

7.  Is there a specific lysophospholipase in human pancreatic juice?

Authors:  R D Duan; B Borgström
Journal:  Biochim Biophys Acta       Date:  1993-04-23

8.  Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice.

Authors:  D L Dillehay; S K Webb; E M Schmelz; A H Merrill
Journal:  J Nutr       Date:  1994-05       Impact factor: 4.798

9.  Ceramides and ceramide metabolites in cell regulation: evidence for dietary sphingolipids as inhibitors of colon carcinogenesis.

Authors:  E M Schmelz; A H Merrill
Journal:  Nutrition       Date:  1998-09       Impact factor: 4.008

10.  Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?

Authors:  E Hertervig; A Nilsson; J Björk; R Hultkrantz; R D Duan
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

View more
  3 in total

1.  Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice.

Authors:  Yao Zhang; Yajun Cheng; Gert H Hansen; Lise-Lotte Niels-Christiansen; Frank Koentgen; Lena Ohlsson; Ake Nilsson; Rui-Dong Duan
Journal:  J Lipid Res       Date:  2010-12-21       Impact factor: 5.922

Review 2.  Sphingolipids in colon cancer.

Authors:  Mónica García-Barros; Nicolas Coant; Jean-Philip Truman; Ashley J Snider; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-09-21

Review 3.  Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.

Authors:  Farzana Parveen; Daniel Bender; Shi-Hui Law; Vineet Kumar Mishra; Chih-Chieh Chen; Liang-Yin Ke
Journal:  Cells       Date:  2019-12-04       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.